Abstract:Burkholderia pseudomallei is an environmental gram-negative bacterium that causes the disease melioidosis and is endemic in many countries of the Asia-Pacific region. In Australia, the mortality rate remains high at approximately 10%, despite curative antibiotic treatment being available. The bacterium is almost exclusively found in the endemic region, which spans the tropical Northern Territory and North Queensland, with clusters occasionally present in more temperate climates. Despite being endemic to North Queensland, these infections remain understudied compared to those of the Northern Territory. This study aimed to assess the prevalence of central nervous system (CNS) disease associated variant bimA Bm , identify circulating antimicrobial resistance mutations and genetically distinct strains from Queensland, via comparative genomics. From 76 clinical isolates, we identified the bimA Bm variant in 20 (26.3%) isolates and in 9 (45%) of the isolates with documented CNS infection (n = 18). Explorative analysis suggests a significant association between isolates carrying the bimA Bm variant and CNS disease (OR 2.8, 95% CI 1.3–6.0, P = 0.009) compared with isolates carrying the wildtype bimA Bp . Furthermore, 50% of isolates were identified as novel multi-locus sequence types, while the bimA Bm variant was more commonly identified in isolates with novel sequence types, compared to those with previously described. Additionally, mutations associated with acquired antimicrobial resistance were only identified in 14.5% of all genomes. The findings of this research have provided clinically relevant genomic data of B . pseudomallei in Queensland and suggest that the bimA Bm variant may enable risk stratification for the development CNS complications and be a potential therapeutic target. Melioidosis is a life-threatening infection, caused by the Gram-negative bacterium Burkholderia pseudomallei , which is endemic to tropical regions in Australia. Variants of the bimA gene have been proposed as a virulence factor associated with more severe disease. In a genomic analysis of 76 clinical B . pseudomallei isolates from Queensland, Australia, we identified that the bimA Bm variant was associated with infection involving the central nervous system (odds ratio 2.8, 95% Confidence Interval: 1.3–6.0, P = 0.009), compared to isolates with the wild-type allele bimA Bp . Half of the isolates from this region were novel multi-locus sequence types, and bimA Bm was more commonly seen in these novel sequence types. Early genomic characterisation to identify virulence factors such as bimA Bm , may be useful as an early marker of more complex disease that could guide further investigation and help determine optimal treatment. Further investigation of a "genomics-guided" approach to the clinical management of this complex infectious disease are warranted.

Flagellin-modulated inflammasome pathways characterize the human alveolar macrophage response to Burkholderia pseudomallei, a lung-tropic pathogen

Activation of Toll-like receptors by Burkholderia pseudomallei

Inhibition of macrophage infectivity potentiator in Burkholderia pseudomallei suppresses pro-inflammatory responses in murine macrophages

Upregulation of Immune Process-Associated Genes in RAW264.7 Macrophage Cells in Response to Burkholderia pseudomallei Infection.

Transcriptome Analysis Reveals Dynamic Changes of Inflammation and Stress Responses during Different Infected Stages with Burkholderia pseudomallei

<i>Burkholderia pseudomallei</i>interferes with host lipid metabolism via<i>NR1D2</i>-mediated<i>PNPLA2/ATGL</i>suppression to block autophagy-dependent inhibition of infection

Role of the type 6 secretion system on apoptosis and macrophage polarization during Burkholderia pseudomallei infection

Heme Oxygenase-1 and Carbon Monoxide Promote Burkholderia pseudomallei Infection

Burkholderia pseudomallei as an Enteric Pathogen: Identification of Virulence Factors Mediating Gastrointestinal Infection

Mapping epigenetic changes to the host cell genome induced by Burkholderia pseudomallei reveals pathogen-specific and pathogen-generic signatures of infection

γδ T Cells Mediate Protection against Neutrophil-associated Lung Inflammation in Pulmonary Melioidosis

Suppression of Host Innate Immune Response by Burkholderia Pseudomallei Through the Virulence Factor Tssm

Differentiation in pyroptosis induction by Burkholderia pseudomallei and Burkholderia thailandensis in primary human monocytes, a possible cause of sepsis in acute melioidosis patients

Glycometabolism change during Burkholderia pseudomallei infection in RAW264.7 cells by proteomic analysis

Legionella-Infected Macrophages Engage the Alveolar Epithelium to Metabolically Reprogram Myeloid Cells and Promote Antibacterial Inflammation

Adhesion and invasion attributes of Burkholderia pseudomallei are dependent on airway surface liquid and glucose concentrations in lung epithelial cells

Pseudomonas aeruginosa LPS or flagellin are sufficient to activate TLR-dependent signaling in murine alveolar macrophages and airway epithelial cells

Clinical Burkholderia pseudomallei isolates from north Queensland carry diverse bimABm genes that are associated with central nervous system disease and are phylogenomically distinct from other Australian strains

Burkholderia pseudomallei known siderophores and hemin uptake are dispensable for lethal murine melioidosis

Machine learning and bioinformatics to identify biomarkers in response to Burkholderia pseudomallei infection in mice

Dysregulated immunologic landscape of the early host response in melioidosis